• Cyclacel Pharmaceuticals Inc., of Berkeley Heights, N.J., said it entered a definitive agreement with Summit, N.J.-based Celgene Corp. to sell four Cyclacel-owned patents related to the use of romidepsin injection for a one-time payment of $5.5 million.